Literature DB >> 21737494

Frequency of undiagnosed cystic lung disease in patients with sporadic renal angiomyolipomas.

Jay H Ryu1, Thomas E Hartman2, Vicente E Torres2, Paul A Decker2.   

Abstract

OBJECTIVE: The aim of this study was to assess the frequency of undiagnosed cystic lung lesions suggestive of pulmonary lymphangioleiomyomatosis (LAM) in patients who received a diagnosis of sporadic renal angiomyolipomas (AMLs).
METHODS: We conducted a retrospective review of CT scans of the chest or abdomen for cystic lung lesions on 176 adult patients who received a diagnosis of sporadic renal AML during a 10-year period, 1997 to 2006, and comparison with chest CT scans of 176 control subjects without renal AML but matched for age, sex, and smoking history. Patients presenting with suspected or known pulmonary LAM and those with underlying tuberous sclerosis were excluded.
RESULTS: Sporadic renal AML was diagnosed in 176 patients with a median age of 58 years (range, 20-91 years), the majority of whom were women (81.8%). Renal tumor was an incidental finding on imaging studies for most patients (90.3%). Nineteen patients (10.8%) had one or more cystic lung lesions and included nine patients (5.1%) with four or more cysts, all of whom were women. In comparison, eight control subjects (4.6%) had one to three cystic lung lesions and none of them exhibited four or more cysts. None of the patients with renal AML and cystic lung lesions, including six women with 10 or more cysts, had undergone an evaluation of their cystic lung disease.
CONCLUSIONS: We conclude that a significant portion of women with sporadic renal AMLs exhibit cystic lung lesions suggestive of pulmonary LAM but may remain undiagnosed. Coexistence of pulmonary LAM should be considered in women incidentally found to have sporadic renal AMLs.

Entities:  

Mesh:

Year:  2011        PMID: 21737494      PMCID: PMC4694079          DOI: 10.1378/chest.11-0669

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  35 in total

Review 1.  The tuberous sclerosis complex.

Authors:  Peter B Crino; Katherine L Nathanson; Elizabeth Petri Henske
Journal:  N Engl J Med       Date:  2006-09-28       Impact factor: 91.245

2.  Angiomyolipoma of the kidney: report of 27 cases and review of the literature.

Authors:  S I Hajdu; F W Foote
Journal:  J Urol       Date:  1969-10       Impact factor: 7.450

3.  mTOR activation, lymphangiogenesis, and estrogen-mediated cell survival: the "perfect storm" of pro-metastatic factors in LAM pathogenesis.

Authors:  Jane Yu; Elizabeth Petri Henske
Journal:  Lymphat Res Biol       Date:  2010-03       Impact factor: 2.589

4.  Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis.

Authors:  D N Franz; A Brody; C Meyer; J Leonard; G Chuck; S Dabora; G Sethuraman; T V Colby; D J Kwiatkowski; F X McCormack
Journal:  Am J Respir Crit Care Med       Date:  2001-08-15       Impact factor: 21.405

5.  Lymphangioleiomyomatosis: abdominopelvic CT and US findings.

Authors:  N A Avila; J A Kelly; S C Chu; A J Dwyer; J Moss
Journal:  Radiology       Date:  2000-07       Impact factor: 11.105

6.  Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis.

Authors:  Denise M Crooks; Gustavo Pacheco-Rodriguez; Rosamma M DeCastro; J Philip McCoy; Ji-an Wang; Fumiyuki Kumaki; Thomas Darling; Joel Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-06       Impact factor: 11.205

7.  Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis.

Authors:  J Yu; A Astrinidis; E P Henske
Journal:  Am J Respir Crit Care Med       Date:  2001-10-15       Impact factor: 21.405

8.  Renal lesion growth in children with tuberous sclerosis complex.

Authors:  D H Ewalt; E Sheffield; S P Sparagana; M R Delgado; E S Roach
Journal:  J Urol       Date:  1998-07       Impact factor: 7.450

9.  Activation of the estrogen receptor contributes to the progression of pulmonary lymphangioleiomyomatosis via matrix metalloproteinase-induced cell invasiveness.

Authors:  Marilyn K Glassberg; Sharon J Elliot; Jason Fritz; Paola Catanuto; Mylene Potier; Roger Donahue; William Stetler-Stevenson; Michael Karl
Journal:  J Clin Endocrinol Metab       Date:  2008-02-19       Impact factor: 5.958

10.  Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells.

Authors:  Jane J Yu; Victoria A Robb; Tasha A Morrison; Eric A Ariazi; Magdalena Karbowniczek; Aristotelis Astrinidis; Chunrong Wang; Lisa Hernandez-Cuebas; Laura F Seeholzer; Emmanuelle Nicolas; Harvey Hensley; V Craig Jordan; Cheryl L Walker; Elizabeth P Henske
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-06       Impact factor: 11.205

View more
  9 in total

Review 1.  Diffuse Cystic Lung Disease. Part I.

Authors:  Nishant Gupta; Robert Vassallo; Kathryn A Wikenheiser-Brokamp; Francis X McCormack
Journal:  Am J Respir Crit Care Med       Date:  2015-06-15       Impact factor: 21.405

Review 2.  Lymphangioleiomyomatosis: New Treatment Perspectives.

Authors:  Elżbieta Radzikowska
Journal:  Lung       Date:  2015-05-17       Impact factor: 2.584

3.  Angiomyolipoma with caval extension and regional nodal involvement: Aggressive behaviour or just rare natural history? Case report and review of literature.

Authors:  Kamaljot Singh Kaler; Rebekah Rittberg; Darrel E Drachenberg
Journal:  Can Urol Assoc J       Date:  2014-03       Impact factor: 1.862

4.  Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells.

Authors:  Chenggang Li; Po-Shun Lee; Yang Sun; Xiaoxiao Gu; Erik Zhang; Yanan Guo; Chin-Lee Wu; Neil Auricchio; Carmen Priolo; Jing Li; Alfredo Csibi; Andrey Parkhitko; Tasha Morrison; Anna Planaguma; Shamsah Kazani; Elliot Israel; Kai-Feng Xu; Elizabeth Petri Henske; John Blenis; Bruce D Levy; David Kwiatkowski; Jane J Yu
Journal:  J Exp Med       Date:  2014-01-06       Impact factor: 14.307

Review 5.  Lymphangioleiomyomatosis: differential diagnosis and optimal management.

Authors:  Kai-Feng Xu; Bee Hong Lo
Journal:  Ther Clin Risk Manag       Date:  2014-08-21       Impact factor: 2.423

6.  Natural history of angiomyolipoma in lymphangioleiomyomatosis: implications for screening and surveillance.

Authors:  Zhao W Yeoh; Vidya Navaratnam; Rupesh Bhatt; Ian McCafferty; Richard B Hubbard; Simon R Johnson
Journal:  Orphanet J Rare Dis       Date:  2014-10-03       Impact factor: 4.123

Review 7.  Lymphangioleiomyomatosis: a clinical review.

Authors:  Anne M O'Mahony; Evelyn Lynn; David J Murphy; Aurelie Fabre; Cormac McCarthy
Journal:  Breathe (Sheff)       Date:  2020-06

8.  Recurrent spontaneous pneumothorax in a 42 years old woman with pulmonary lymphangioleiomyomatosis: insights and pitfalls of the surgical treatment.

Authors:  Kyriakos Spiliopoulos; Angeliki Tsantsaridou; Rodula Papamichali; Konstantina Kimpouri; Nicolaos S Salemis; George K Koukoulis; Nicolaos B Tsilimingas
Journal:  J Clin Med Res       Date:  2013-01-11

9.  Factors associated with the number and size of renal angiomyolipomas in sporadic angiomyolipoma (sAML): a study of adult patients with sAML managed in a Dutch tertiary referral center.

Authors:  J L H Ruud Bosch; Francis Vekeman; Mei Sheng Duh; Maureen Neary; Matthew Magestro; Jonathan Fortier; Paul Karner; Raluca Ionescu-Ittu; Bernard A Zonnenberg
Journal:  Int Urol Nephrol       Date:  2018-01-15       Impact factor: 2.370

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.